drugset

drugset / Trial / NCT00353379

Pharmacology of Cognition in Schizotypal Personality Disorder

NCT00353379 ↗

Phase 4 Terminated 29 enrolled Icahn School of Medicine at Mount Sinai National Institute of Mental Health (NIMH) · collab

RandomizedCrossoverDouble-blindTreatment

Summary

This study will determine the effectiveness of guanfacine in improving cognitive and functional impairments in schizotypal personality disorder.

Timeline

Start: 1995-09
Primary completion: 1997-05
Completion: 1997-05

Publications

Results McClure MM, Barch DM, Romero MJ, Minzenberg MJ, Triebwasser J, Harvey PD, Siever LJ. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry. 2007 May 15;61(10):1157-60. doi: 10.1016/j.biopsych.2006.06.034. Epub 2006 Sep 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Guanfacine	Small molecule	—	—

Indications